Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesus Garcia-Donas

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|April 27, 2018
Metastatic Prostate CancerJuan F Rodriguez‑Moreno, Jesus Garcia‑Donas
Seminars in Oncology|August 27, 2013
Molecular markers to predict response to therapyJesus Garcia-Donas, Cristina Rodriguez-Antona, Eric Jonasch
European Urology Focus|July 21, 2017
Genotyping the Host in the Battle Against CancerJesus Garcia-Donas, Sandra Falagan, Juan Francisco Rodriguez-Moreno
Urologic Oncology|February 6, 2014
Renal carcinoma pharmacogenomics and predictors of response: Steps toward treatment individualizationJesus Garcia-Donas, Juan Francisco Rodriguez-Moreno, Nuria Romero-Laorden, et al.
Gynecologic Oncology|March 25, 2014
Circulating and disseminated tumor cells in ovarian cancer: a systematic reviewNuria Romero-Laorden, David Olmos, Tanja Fehm, et al.
Critical Reviews in Oncology/Hematology|April 9, 2013
Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysisIvan Diaz-Padilla, Nuria Romero, Eitan Amir, et al.
Ecancermedicalscience|January 4, 2014
Borderline tumours of the ovary, current controversies regarding their diagnosis and treatmentMaría Guadalupe Patrono, Lucas Minig, Ivan Diaz-Padilla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Retrorectal cystic hamartoma as benign cause of CA 19-9 elevationJesus Garcia-Donas, Nuria Rodriguez, Carlos Jara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Cytochrome P17 inhibition with ketoconazole as treatment for advanced granulosa cell ovarian tumorJesus Garcia-Donas, Alicia Hurtado, Zaida García-Casado, et al.
The Lancet. Oncology|October 22, 2011
Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective studyJesus Garcia-Donas, Emilio Esteban, Luis Javier Leandro-García, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|April 27, 2018
Metastatic Prostate CancerJuan F Rodriguez‑Moreno, Jesus Garcia‑Donas
Seminars in Oncology|August 27, 2013
Molecular markers to predict response to therapyJesus Garcia-Donas, Cristina Rodriguez-Antona, Eric Jonasch
European Urology Focus|July 21, 2017
Genotyping the Host in the Battle Against CancerJesus Garcia-Donas, Sandra Falagan, Juan Francisco Rodriguez-Moreno
Urologic Oncology|February 6, 2014
Renal carcinoma pharmacogenomics and predictors of response: Steps toward treatment individualizationJesus Garcia-Donas, Juan Francisco Rodriguez-Moreno, Nuria Romero-Laorden, et al.
Gynecologic Oncology|March 25, 2014
Circulating and disseminated tumor cells in ovarian cancer: a systematic reviewNuria Romero-Laorden, David Olmos, Tanja Fehm, et al.
Critical Reviews in Oncology/Hematology|April 9, 2013
Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysisIvan Diaz-Padilla, Nuria Romero, Eitan Amir, et al.
Ecancermedicalscience|January 4, 2014
Borderline tumours of the ovary, current controversies regarding their diagnosis and treatmentMaría Guadalupe Patrono, Lucas Minig, Ivan Diaz-Padilla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Retrorectal cystic hamartoma as benign cause of CA 19-9 elevationJesus Garcia-Donas, Nuria Rodriguez, Carlos Jara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Cytochrome P17 inhibition with ketoconazole as treatment for advanced granulosa cell ovarian tumorJesus Garcia-Donas, Alicia Hurtado, Zaida García-Casado, et al.
The Lancet. Oncology|October 22, 2011
Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective studyJesus Garcia-Donas, Emilio Esteban, Luis Javier Leandro-García, et al.
Pageof 3